THE ASTRAZENECA vaccine rollout has been dogged by problems in Europe, with many countries sitting on unused supplies over blood clot fears. Despite regulatory bodies concluding there is no causation, rare cases of blood clots do appear to be greater in a younger cohort. Now Professor Neil Ferguson has weighed in on the developing situation.

Main Source link